FDA Announces Proposed Collection of Information for Human Drug Compounding Activities

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to human drug compounding, repackaging, and related activities, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.